Research Summaries

Research Summary
Research Summary
07/01/2025
Kate Young
In a large multicenter randomized trial, intrapartum oral sildenafil citrate did not reduce adverse perinatal outcomes related to fetal hypoxia compared with placebo.
07/01/2025
ASCO Conference Coverage
ASCO Conference Coverage
06/30/2025
Kate Young
A retrospective study presented at the American Society of Clinical Oncology 2025 annual meeting evaluated women with endometrial neuroendocrine tumors and found that adjuvant treatment with...
06/30/2025
FDA Alert
FDA Alert
06/20/2025
Miranda Manier, BA
The FDA has approved mitomycin intravesical solution for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.
06/20/2025
Research Summary
Research Summary
06/17/2025
Kate Young
Robotic surgery significantly reduced the 3-year locoregional recurrence rate and improved disease-free survival in patients with middle or low rectal cancer compared with conventional laparoscopic surgery....
06/17/2025
Research Summary
Research Summary
06/10/2025
Anthony Calabro, MA
In women with dense breast tissue and a negative screening mammogram, abbreviated MRI and contrast-enhanced mammography tripled the detection rate of invasive breast cancer compared with automated breast...
06/10/2025
ASCO Conference Coverage
ASCO Conference Coverage
06/09/2025
Miranda Manier, BA
A cross-sectional study identifies key predictors of peritonitis in ovarian cancer hospitalizations, highlighting early intervention opportunities.
06/09/2025
Conference Coverage
Conference Coverage
06/06/2025
Anthony Calabro, MA
Patients with breast cancer and coexisting chronic lymphocytic leukemia (CLL) present with more advanced disease and poorer survival compared with those without CLL, according to the results of a...
06/06/2025
ASCO Conference Coverage
ASCO Conference Coverage
06/05/2025
Anthony Calabro, MA
Researchers found that the combination of benmelstobart, chemotherapy, and anlotinib yields improved response and progression-free survival in patients with advanced or recurrent endometrial cancer,...
06/05/2025
FDA Alert
FDA Alert
06/04/2025
Kate Young
The FDA announced the approval of darolutamide for treating metastatic castration-sensitive prostate cancer. This review was conducted under Project Orbis, which allows for concurrent submission and review...
06/04/2025
ASCO Conference Coverage
ASCO Conference Coverage
06/04/2025
Anthony Calabro, MA
The results of a large retrospective analysis noted significant age-related differences in the germline landscape of endometrial cancer. This study was presented as a poster at the 2025 American Society of...
06/04/2025